(Q24814698)

5 July 2017

title

Cost-effectiveness of highly active antiretroviral therapy in South Africa (English)

1 reference

cost-effectiveness analysis

5 July 2017

main subject

anti-retroviral agent

0 references

South Africa

0 references

1 reference

4

Linda-Gail Bekker

1 reference

5 July 2017

Motasim Badri

1

0 references

Gary Maartens

object named as

Gary Maartens

2

0 references

Robert W. Platt

object named as

Robert W Platt

6

0 references

Robin Wood

7

object named as

Robin Wood

1 reference

5 July 2017

Sundhiya Mandalia

3

1 reference

5 July 2017

John R Penrod

5

1 reference

5 July 2017

Eduard J Beck

8

1 reference

5 July 2017

language of work or name

English

0 references

publication date

6 December 2005

1 reference

5 July 2017

1 reference

5 July 2017

volume

3

1 reference

5 July 2017

issue

1

1 reference

5 July 2017

page(s)

e4

1 reference

Creative Commons Attribution 4.0 International

5 July 2017

copyright license

start time

6 December 2005

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Interim proposal for a WHO Staging System for HIV infection and Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1298940

Initiating highly active antiretroviral therapy in sub-Saharan Africa: an assessment of the revised World Health Organization scaling-up guidelines

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1298940

South Africa takes first steps to provide antiretrovirals

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1298940

Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1298940

Preventing antiretroviral anarchy in sub-Saharan Africa

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1298940

The cost of HIV treatment and care. A global review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1298940

The changing impact of HIV/AIDS on Kenyatta National Hospital, Nairobi from 1988/89 through 1992 to 1997.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1298940

Cost effectiveness of combination HIV therapy: 3 years later

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1298940

Admission trends in a rural South African hospital during the early years of the HIV epidemic

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1298940

AIDS and hospital bed occupancy: an overview

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1298940

Changing presentation and survival, service utilization and costs for AIDS patients: insights from a London referral centre

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1298940

Changing use of hospital services and costs at a London AIDS referral centre, 1983-1989.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1298940

Bed occupancy due to HIV/AIDS in an urban hospital medical ward in Uganda.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1298940

Discounting and health benefits

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1298940

Direct costs for the treatment of HIV-infection in a German cohort after the introduction of HAART.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1298940

Exploring the costs of a limited public sector antiretroviral treatment programme in South Africa.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1298940

Health service use and household expenditure during terminal illness due to AIDS in rural Tanzania

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1298940

The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1298940

Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1298940

The cost effectiveness of combination antiretroviral therapy for HIV disease.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1298940

Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1298940

Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients. Swiss HIV Cohort Study.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1298940

The impact of HIV on resource utilization by patients with tuberculosis in a tertiary referral hospital, Nairobi, Kenya

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1298940

Effect of HAART on health status and hospital costs of severe HIV-infected patients: a modeling approach

28 November 2018

1 reference

12 December 2020

Impact of combination therapy for HIV infection on inpatient census

1 reference

12 December 2020

Adherence is not a barrier to successful antiretroviral therapy in South Africa

2 references

12 December 2020

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.0030004

7 January 2021

inferred from DOI database lookup

The use and cost of HIV service provision in England in 1996. National Prospective Monitoring System (NPMS) Steering Group and NPMS Working Party on Costs

1 reference

12 December 2020

Decreased morbidity and use of hospital services in English HIV-infected individuals with increased uptake of anti-retroviral therapy 1996-1997. National Prospective Monitoring System Steering Group

1 reference

12 December 2020

The cost-effectiveness of highly active antiretroviral therapy, Canada 1991-2001

1 reference

12 December 2020

Assessing the cost-effectiveness of HAART for adults with HIV in England

1 reference

12 December 2020

10.1371/JOURNAL.PMED.0030004

Identifiers

DOI

1 reference

OpenCitations bibliographic resource ID

5 July 2017

2315838

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

5 July 2017

1 reference